ClinicalTrials.gov record
Recruiting No phase listed Observational

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

ClinicalTrials.gov ID: NCT00898313

Public ClinicalTrials.gov record NCT00898313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Molecular Predictors of Lung Cancer Behavior

Study identification

NCT ID
NCT00898313
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Vanderbilt-Ingram Cancer Center
Other
Enrollment
4,000 participants

Conditions and interventions

Conditions

Interventions

  • Blood draw Procedure
  • Urine collection Procedure
  • biologic sample preservation procedure Other
  • comparative genomic hybridization Genetic
  • fine needle aspiration of the lung Procedure
  • fluorescence bronchoscopy with airway biopsy Procedure
  • gene expression microarray analysis Genetic
  • nasal brushing Procedure
  • proteomic profiling analysis Genetic
  • sputum sample Procedure
  • thoracentesis Procedure

Procedure · Other · Genetic

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Jan 30, 2027
Completion
Jan 30, 2027
Last update posted
Apr 26, 2026

2003 – 2027

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37212 Recruiting
Veterans Affairs Medical Center - Nashville Nashville Tennessee 37212 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00898313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00898313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →